Guo M, Mi J, Jiang QM, Xu JM, Tang YY, Tian G, et al
Nevertheless, prescribers must evaluate each patient individually, considering their complete medical history, current medications, cardiovascular risk factors, and treatment goals
GLP-1 RAs reduced LDL cholesterol in multiple populations with metabolic disorders, including individuals with overweight or obesity and antipsychotic-treated psychotic disorders (Class IV
64 The glucose-lowering effects of GLP-1RAs are predominantly attributed to their modulation of gastric emptying rather than their direct pancreatic effects
We also help clients explore discount programs and cost-saving options based on their treatment plans